Effect of bile duct obstruction on hepatic uptake of 1-methyl-4-phenylpyridinium in the rat

Pharmacological Research

Volumn 37, Issue 6, 1998, Pages 497-504

  Martel, F ^a   Calhau, C ^a   Hipolito Reis C ^a  

^a Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

Cholestasis; MPP+; Rat liver; Transport

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; GLYCOPROTEIN P; TYPE 1 HEPATIC TRANSPORTER OF ORGANIC CATION; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; CATION TRANSPORT; CELL INFILTRATION; CONTROLLED STUDY; EXTRAHEPATIC BILE DUCT OBSTRUCTION; INFLAMMATORY CELL; LIVER; LIVER CELL; LIVER SLICE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032100774     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0325     Document Type: Article

References (24)

1. 1. Meijer D, Mol W, Muller M, Kurz G. Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations. J Pharmacokinet Biopharm 1990; 18: 35-70.
2. 2. Oude Elferink RPJ, Meijer DKF, Kuipers F, Jansen PLM, Groen AK, Groothuis GMM. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim Biophys Acta 1995; 1241: 215-68.
3. 3. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994; 372: 549-52.
4. + in isolated rat hepatocytes: putative involvement of a P-glycoprotein transporter. Br J Pharmacol 1996; 119: 1519-24.
5. 5. Klaassen CD, Watkins III JB. Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev 1984; 36: 1-67.
6. 6. Watkins III JB, Klaassen CD. Mechanisms of drug-induced cholestasis. In: Cameron RG, Feuer G, de la Iglesia FA, eds. Drug-induced Hepatotoxicity. Handbook of Experimental Pharmacology 121. Berlin: Springer-Verlag, 1996: pp. 155-83.
7. 7. Schrenk D, Gant TW, Preisegger K-H, Silverman JA, Marino PA, Thorgeirsson SS. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 1993; 17: 854-60.
8. 8. Accatino L, Pizarro M, Solis N, Koenig CS, Vollrath V, Chianale J. Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat. J Hepatol 1996; 25: 349-61.
9. 9. Balistreri WF, Rej R. Liver function. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. 2nd ed. Philadelphia: Saunders, 1994: pp. 1449-512.
10. + in freshly isolated rat hepatocytes: evidence for interaction with catecholamines. Naunyn-Schmiedeberg's Arch Pharmacol 1996; 354: 305-11.
11. 11. Bradford M. A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
12. 12. Martel F, Vetter T, Russ H, Gründemann D, Azevedo I, Koepsell H, Schömig E. Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1. Naunyn-Schmiedeberg's Arch Pharmacol 1996; 354: 320-6.
13. 13. Wannagat FJ, Adler RD, Ockner RK. Bile acid-induced increase in bile acid-independent flow and plasma membrane Na,K-ATPase activity in rat liver. J Clin Invest 1978; 61: 297-307.
14. 14. Muriel P, Suarez OR, Gonzalez P, Zuniga L. Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach. J Hepatol 1994; 21: 95-102.
15. 15. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumours and tissues. Proc Natl Acad Sci USA 1987; 84: 265-9.
16. 16. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 1993; 62: 385-427.
17. 17. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, Van Deemter L, Mol CAAM, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-62.
18. 18. Gall JA, Bhathal PS. A quantitative analysis of the liver following ligation of the common bile duct. Liver 1990; 10: 116-25.
19. 19. Slott PA, Liu MH, Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990; 99: 466-77.
20. 20. Desmet VJ. Histopathology of cholestasis. Verh Dtsch Ges Pathol 1995; 79: 233-40.
21. 21. Tuchweber B, Desmouliere A, Bochaton-Piallat ML, Rubbia-Brandt L, Gabbiani G. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 1996; 74: 265-78.
22. 22. Graefe K-H, Bönisch H. The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurones. In: Trendelenburg U, Weiner N, eds. Catecholamines I. Handbook of Experimental Pharmacology, vol. 90/I. Berlin: Springer-Verlag, 1988: pp. 193-245.
23. 23. Trendelenburg U. The extraneuronal uptake and metabolism of catecholamines. In: Trendelenburg U, Weiner N, eds. Catecholamines I. Handbook of Experimental Pharmacology, vol. 90/I. Berlin: Springer-Verlag, 1988: pp. 279-319.
24. 24. Martel F, Martins MJ, Calhau C, Hipólito-Reis C, Azevedo I. Postnatal development of organic cation transport in the rat liver. Pharmacol Res, 1998; 37, 131-6.